Vistin Pharma ASA (VISTN) — Cash Flow Reinvestment Rate

Latest as of June 2025: 1.08x

Vistin Pharma ASA (VISTN) has a Cash Flow Reinvestment Rate of 1.08x as of June 2025, reinvesting Nkr6.87 Million (capex Nkr3.43 Million plus investments Nkr-3.43 Million) from operating cash flow of Nkr6.37 Million. Check Vistin Pharma ASA (VISTN) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.08x
(Capex + Investments) / Operating CF

Total Reinvested

Nkr6.87 Million
Capex + Investments

Operating Cash Flow

Nkr6.37 Million
NOK

Capital Expenditures

Nkr3.43 Million
NOK

Vistin Pharma ASA Cash Flow Reinvestment Rate (2016–2024)

Historical reinvestment intensity for Vistin Pharma ASA across 6 annual periods. Explore how well can Vistin Pharma ASA service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Vistin Pharma ASA (2016–2024)

Year-by-year capital reinvestment analysis for Vistin Pharma ASA. For live market cap and broader valuation context, see VISTN company net worth.

Year Reinvestment Rate Total Reinvested (NOK) Operating CF Capex YoY Change
2024 0.75x Nkr81.10 Million Nkr107.86 Million Nkr40.80 Million ▲ +91.4%
2023 0.39x Nkr35.58 Million Nkr90.59 Million Nkr17.90 Million ▼ -91.6%
2021 4.65x Nkr63.62 Million Nkr13.68 Million Nkr31.94 Million ▲ +139.8%
2019 1.94x Nkr36.71 Million Nkr18.93 Million Nkr18.36 Million ▼ -88.4%
2017 16.67x Nkr158.48 Million Nkr9.51 Million Nkr35.55 Million ▲ +2672.1%
2016 0.60x Nkr32.37 Million Nkr53.84 Million Nkr16.27 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow